Wait first, then levetiracetam + Levetiracetam first, then wait
Phase 1UNKNOWN 0 watching 0 views this week💤 Quiet
30
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Aphasia
Conditions
Aphasia, Stroke
Trial Timeline
Sep 1, 2005 → Dec 1, 2021
NCT ID
NCT00227461About Wait first, then levetiracetam + Levetiracetam first, then wait
Wait first, then levetiracetam + Levetiracetam first, then wait is a phase 1 stage product being developed by UCB for Aphasia. The current trial status is unknown. This product is registered under clinical trial identifier NCT00227461. Target conditions include Aphasia, Stroke.
Hype Score Breakdown
Clinical
10
Activity
5
Company
7
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00227461 | Phase 1 | UNKNOWN |
Competing Products
3 competing products in Aphasia
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| memantine + memantine + placebo | Lundbeck | Approved | 82 |
| memantine | Lundbeck | Approved | 82 |
| Neflamapimod + Placebo | CervoMed | Phase 2 | 44 |